Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Glycosaminoglycan overproduction in the aorta increases aortic calcification in murine chronic kidney disease.

Purnomo E, Emoto N, Nugrahaningsih DA, Nakayama K, Yagi K, Heiden S, Nadanaka S, Kitagawa H, Hirata K.

J Am Heart Assoc. 2013 Aug 28;2(5):e000405. doi: 10.1161/JAHA.113.000405.

2.

EXTL2 controls liver regeneration and aortic calcification through xylose kinase-dependent regulation of glycosaminoglycan biosynthesis.

Nadanaka S, Kitagawa H.

Matrix Biol. 2014 Apr;35:18-24. doi: 10.1016/j.matbio.2013.10.010. Review.

3.

p53 negatively regulates the osteogenic differentiation of vascular smooth muscle cells in mice with chronic kidney disease.

Li KL, Chen J, Li ZH, Zhao L, He YN.

Cardiovasc J Afr. 2012 Jul 12;23(6):e1-9. doi: 10.5830/CVJA-2011-069.

4.

Medial and intimal calcification in chronic kidney disease: stressing the contributions.

Rogers M, Goettsch C, Aikawa E.

J Am Heart Assoc. 2013 Sep 23;2(5):e000481. doi: 10.1161/JAHA.113.000481. No abstract available.

5.

Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency.

Jimbo R, Kawakami-Mori F, Mu S, Hirohama D, Majtan B, Shimizu Y, Yatomi Y, Fukumoto S, Fujita T, Shimosawa T.

Kidney Int. 2014 May;85(5):1103-11. doi: 10.1038/ki.2013.332.

PMID:
24088960
6.

Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet.

Lau WL, Leaf EM, Hu MC, Takeno MM, Kuro-o M, Moe OW, Giachelli CM.

Kidney Int. 2012 Dec;82(12):1261-70. doi: 10.1038/ki.2012.322.

7.

Sodium-dependent phosphate cotransporters and phosphate-induced calcification of vascular smooth muscle cells: redundant roles for PiT-1 and PiT-2.

Crouthamel MH, Lau WL, Leaf EM, Chavkin NW, Wallingford MC, Peterson DF, Li X, Liu Y, Chin MT, Levi M, Giachelli CM.

Arterioscler Thromb Vasc Biol. 2013 Nov;33(11):2625-32. doi: 10.1161/ATVBAHA.113.302249.

8.

High phosphorus level leads to aortic calcification via β-catenin in chronic kidney disease.

Yao L, Sun YT, Sun W, Xu TH, Ren C, Fan X, Sun L, Liu LL, Feng JM, Ma JF, Wang LN.

Am J Nephrol. 2015;41(1):28-36. doi: 10.1159/000370250.

PMID:
25634106
9.

Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress.

Wei Q, Ren X, Jiang Y, Jin H, Liu N, Li J.

BMC Cardiovasc Disord. 2013 Mar 5;13:13. doi: 10.1186/1471-2261-13-13.

10.

Vitamin D and vascular calcification in chronic kidney disease.

Rodriguez M, Martinez-Moreno JM, Rodríguez-Ortiz ME, Muñoz-Castañeda JR, Almaden Y.

Kidney Blood Press Res. 2011;34(4):261-8. doi: 10.1159/000326903. Review.

11.

Apelin: A novel inhibitor of vascular calcification in chronic kidney disease.

Han X, Wang LY, Diao ZL, Liu WH.

Atherosclerosis. 2016 Jan;244:1-8. doi: 10.1016/j.atherosclerosis.2015.10.102.

PMID:
26581047
12.

Fetuin-A protects against atherosclerotic calcification in CKD.

Westenfeld R, Schäfer C, Krüger T, Haarmann C, Schurgers LJ, Reutelingsperger C, Ivanovski O, Drueke T, Massy ZA, Ketteler M, Floege J, Jahnen-Dechent W.

J Am Soc Nephrol. 2009 Jun;20(6):1264-74. doi: 10.1681/ASN.2008060572.

13.

Pathophysiology of vascular calcification in chronic kidney disease.

Moe SM, Chen NX.

Circ Res. 2004 Sep 17;95(6):560-7. Review.

14.

Transglutaminase 2 accelerates vascular calcification in chronic kidney disease.

Chen NX, O'Neill K, Chen X, Kiattisunthorn K, Gattone VH, Moe SM.

Am J Nephrol. 2013;37(3):191-8. doi: 10.1159/000347031.

PMID:
23466870
15.

Replicative senescence of vascular smooth muscle cells enhances the calcification through initiating the osteoblastic transition.

Nakano-Kurimoto R, Ikeda K, Uraoka M, Nakagawa Y, Yutaka K, Koide M, Takahashi T, Matoba S, Yamada H, Okigaki M, Matsubara H.

Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1673-84. doi: 10.1152/ajpheart.00455.2009.

16.

Klotho deficiency causes vascular calcification in chronic kidney disease.

Hu MC, Shi M, Zhang J, Quiñones H, Griffith C, Kuro-o M, Moe OW.

J Am Soc Nephrol. 2011 Jan;22(1):124-36. doi: 10.1681/ASN.2009121311.

17.

Enhanced mineralization potential of vascular cells from SM22α-Rankl (tg) mice.

Morony S, Sage AP, Corbin T, Lu J, Tintut Y, Demer LL.

Calcif Tissue Int. 2012 Dec;91(6):379-86. doi: 10.1007/s00223-012-9655-9.

18.

Inorganic phosphate accelerates the migration of vascular smooth muscle cells: evidence for the involvement of miR-223.

Rangrez AY, M'Baya-Moutoula E, Metzinger-Le Meuth V, Hénaut L, Djelouat MS, Benchitrit J, Massy ZA, Metzinger L.

PLoS One. 2012;7(10):e47807. doi: 10.1371/journal.pone.0047807.

19.

Vascular calcification in chronic kidney disease.

Jono S, Shioi A, Ikari Y, Nishizawa Y.

J Bone Miner Metab. 2006;24(2):176-81. Review.

PMID:
16502129
20.

Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE-/-) mice with chronic renal failure.

Phan O, Ivanovski O, Nikolov IG, Joki N, Maizel J, Louvet L, Chasseraud M, Nguyen-Khoa T, Lacour B, Drüeke TB, Massy ZA.

Nephrol Dial Transplant. 2008 Jan;23(1):82-90.

Items per page

Supplemental Content

Support Center